Volume 4, Issue 1, Page 1 (January 2008)
4 of 29
PREVIEW
FULL TEXT
FULL-TEXT PDF (170 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
PHILADELPHIA — Brand and generic formulations of an epilepsy drug that meet federal standards for bioequivalence might have substantially different clinical effects.
PII: S1553-3212(08)70033-5
doi:10.1016/S1553-3212(08)70033-5
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.